BioSpace News Archive

Drug Development

Merck’s KEYTRUDA® (pembrolizumab) Demonstrates Improved Overall Survival as First-Line Treatment of Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma at Final Analysis of Pivotal Phase 3 KEYNOTE-048 Trial

Survival Benefit Now Observed with KEYTRUDA in Combination with Chemotherapy in All Patient Populations (Regardless of PD-L1 Expression) and with KEYTRUDA Monotherapy in Patients Whose Tumors Expressed PD-L1 at CPS ≥1

May 31, 2019
·
37 min read
111, Inc. to Attend the Credit Suisse 2019 Asia Healthcare Corporate Days in Hong Kong, June 5-6, 2019

111, Inc. announced that the Company will participate in the Credit Suisse 2019 Asia Healthcare Corporate Days in Hong Kong, June 5-6, 2019.

May 31, 2019
·
1 min read
Business

Seattle Sperm Bank Opens Facility in La Jolla, California

The Seattle Sperm Bank announces the opening of its 3rd laboratory location, at 8950 Villa La Jolla Drive, Suite B214, La Jolla, CA 92037.

May 31, 2019
·
2 min read
Policy

Better, faster, stronger: Report calls for stronger tobacco control measures

Canada is failing its youth when it comes to tobacco control, according to a 2019 Report, released by the Tobacco Endgame Cabinet.

May 31, 2019
·
4 min read
EmeTerm and HeadaTerm Approved by TGA Australia

WAT Medical, a company that develops safe, effective, and user-friendly wearable medical products, recently announced that HeadaTerm, its migraine treatment product, has received official clearance from TGA Australia.

May 31, 2019
·
2 min read
Deals

Swedish Match AB (publ) Share Capital and Total Number of Shares

In accordance with the resolution at the Annual General Meeting on April 9, 2019, Swedish Match AB has cancelled 6,000,000 repurchased treasury shares.

May 31, 2019
·
1 min read
Business

Beam Therapeutics and Bio Palette Announce Exclusive License Agreements for Base Editing Technologies

Beam Therapeutics and Bio Palette announced an exclusive cross-license agreement around each companies’ base editing intellectual property.

May 31, 2019
·
3 min read
Deals

Exact Sciences to participate in June investor conferences - May 31, 2019

Exact Sciences Corp. announced that company management will be presenting at the following investor conferences and invited investors to participate by webcast.

May 31, 2019
·
4 min read
Business

Rakuten Medical Opens Two New Offices In The Netherlands And Taiwan, Adding New Jobs To Strengthen And Expand Its Global Presence

Rakuten Medical, a clinical-stage biotechnology company developing precision-targeted cancer therapies based on its proprietary photoimmunotherapy platform, has established new office locations in both Amsterdam, Netherlands and Taipei, Taiwan to further strengthen its position in these geographic areas.

May 31, 2019
·
5 min read
Witty Health Unveils Prescription Drug- Use Related Software (PDURS) Platform at American Society of Clinical Oncology (ASCO) Conference

Witty Health Inc., an oncology-focused digital health company has announced the release of Prescription Drug- Use Related Software services on OncoPower, an oncologist-designed platform that utilizes digital health and professional networking to improve cancer care and precision medicine.

May 31, 2019
·
3 min read